题名

中醫治療巴金森氏病病例報告

并列篇名

Traditional Chinese Medicine Treatment of Parkinson's Disease Patient

DOI

10.6516/TJTCM.201803_21(1).0020

作者

吳靜欣(Ching-Hsin Wu)；周宗翰(Zong-Han Zhou)；陳美如(Mei-Ru Chen)；林舜穀(Shun-Ku Lin)

关键词

巴金森氏病 ； 中醫 ； 疏肝解鬱 ； 抑肝散 ； Parkinson's Disease ； Traditional Chinese medicine ； course the liver and resolve depression ； Yi-Gan San

期刊名称

中醫藥研究論叢

卷期/出版年月

21卷1期（2018 / 03 / 30）

页次

247 - 253

内容语文

繁體中文
中文摘要

巴金森氏病是常見的退化性腦部疾病，造成患者無法控制的肢體震顫、運動遲緩、身體僵硬、以及步態不穩，患者常由於對身體的喪失自主、以及對疾病預後的悲觀預期，導致嚴重的情緒低落。本病案以平抑肝氣、鎮痙安神輔以益氣健脾、疏肝解鬱方式治療巴金森氏病患者，病患服藥後食慾、情緒及身體無力等症狀明顯改善，希望本病案可以作為臨床中醫師診治巴金森氏病患者的參考。
英文摘要

Parkinson's disease is a common degenerative brain disease in Taiwan that causes uncontrolled physical tremors, slow movement, stiffness, and gait instability. Patients often suffer from loss of autonomy and pessimistic prognosis for disease, Leading to severe depression. The case of the case to calm the liver qi, sedative qi and soothe the nerves combined with Qi and spleen, liver qi stagnation treatment of patients with Parkinson's disease cases. After treatment, the appetite, mood and physical weakness improved significantly; The presented case could be a reference for clinicians in the diagnosis and treatment of patients with Parkinson's disease.
主题分类 醫藥衛生 > 中醫藥學
醫藥衛生 > 藥理醫學
参考文献
  1. Connolly, BS,Lang, AE(2004).Pharmacological treatment of Parkinson disease: a review.JAMA,311(16),1670-83.
  2. Doo, AR,Kim, SN,Park, JY,Cho, KH,Hong, J,Eun-Kyung, K,Moon, SK,Jung, WS,Lee, H,Jung, JH,Park, HJ(2010).Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTPinduced cytotoxicity in vitro and in vivo.J Ethnopharmacol,131(2),433-42.
  3. Fasano, A,Daniele, A,Albanese, A(2012).Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation.Lancet Neurol,11,429-42.
  4. Gelb, DJ,Oliver, E,Gilman, S(1999).Diagnostic criteria for Parkinson disease.Arch Neurol,56(1),33.
  5. Hatano, T,Hattori, N,Kawanabe, T,Terayama, Y,Suzuki, N,Iwasaki, Y,Fujioka, T,Yokukansan Parkinson's Disease Study Group(2014).An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease.J Neural Transm,121(3),275-81.
  6. Hodm, MM,Yahr, MD(1967).Parkinsonism: onset, progression, and mortality.Neurology,17,427-42.
  7. Hornykiewicz, O(2006).The discovery of dopamine deficiency in the parkinsonian brain.J Neural Transm (suppl),70,9-15.
  8. Hussl, A,Seppi, K,Poewe, W(2013).Nonmotor symptoms in Parkinson's disease.Expert Rev Neurother,13(6),581-3.
  9. Jankovic, J,Sherer, T(2014).The future of research in Parkinson disease.JAMA Neurol,71(11),1351.
  10. Langston, JW(2006).The Parkinson's complex: parkinsonism is just the tip of the iceberg.Ann Neurol,59(4),591.
  11. Maloney, EM,Djamshidian, A,O'Sullivan, SS(2017).Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations.J Neurol Sci,374
  12. Noyce, AJ,Bestwick, JP,Silveira-Moriyama, L,Hawkes, CH,Giovannoni, G,Lees, AJ,Schrag, A(2012).Meta-analysis of early nonmotor features and risk factors for Parkinson disease.Ann Neurol,72(6),893-901.
  13. Pringsheim, T,Jette, N,Frolkis, A,Steeves, TD(2014).The prevalence of Parkinson's disease: a systematic review and meta-analysis.Mov Disord,29(13),1583.
  14. Van Den Eeden, SK,Tanner, CM,Bernstein, AL,Fross, RD,Leimpeter, A,Bloch, DA,Nelson, LM(2003).Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.Am J Epidemiol,157(11),1015.
  15. 李政育(2010)。帕金森氏症候群中醫證治。中醫內科醫學雜誌，8(1)，10-14。
  16. 程士德編(1999)。內經。台北:知音出版社。
  17. 程維德(2014)。巴金森氏病之中西醫學治療研究。中國鍼灸學雜誌，2(1)，65-91。
print cancel